Tuesday, June 30, 2020

Hoth Agrees with Va. Commonwealth U on Potential Covid Treatment Research

›
Hoth Therapeutics , Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced entering into a sponsored research agreement with Vir...

Sun BioPharma’s SBP-101 Fast Track’d for type of pancreatic cancer

›
The FDA designates Sun BioPharma’s ( OTCQB:SNBP ) lead candidate SBP-101 for Fast Track review for the treatment of patients with pancreat...

Cellular Biomedicine to update on pipeline July 13

›
Cellular Biomedicine (NASDAQ: CBMG ) will  host  an online investor event  on Monday, July 13, at 8:00 AM ET to update investors on its cli...

T2 Bio.systems launches COVID-19 molecular diagnostic test in U.S

›
T2 Biosystems has completed the validation of its T2SARS-CoV-2 Panel, its molecular test for COVID-19. Commercial launch is underway under...

Nasdaq’s $1.2 trillion biotech index draws Europe’s COVID drug hunters

›
Spain’s Pharma Mar is looking at listing on New York’s Nasdaq market, joining a flurry of biotech companies aiming to tap investors’ voraci...

FDA OKs Ultragenyx’s Dojolvi for rare metabolic disorders

›
The FDA approves Ultragenyx’s (NASDAQ: RARE ) Dojolvi (triheptanoin) for the treatment of pediatric and adult patients with molecularly con...

Y-mAbs starts rolling U.S. application for omburtamab for type of pediatric cancer

›
Y-mAbs Therapeutics (NASDAQ: YMAB ) launches the  rolling submission of its U.S. marketing application seeking approval of omburtamab for ...